salmeterol xinafoate
PolandDrugs containing this active substance
-
The medicine is used to prevent breathing difficulties that may be caused by asthma. It helps to prevent shortness of breath and wheezing.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol xinafoate 25 mcg fluticasone propionate No input provided ATC: R03AK06
Manufacturer: Salutas Pharma GmbH
-
The medicine is used to prevent breathing difficulties that may be caused by asthma. It helps to prevent shortness of breath and wheezing.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol xinafoate 25 mcg fluticasone propionate No input provided ATC: R03AK06
Manufacturer: Salutas Pharma GmbH
-
The medicine is used in the treatment of bronchial asthma. It contains substances that dilate the airways and reduce swelling and inflammation in the lungs.
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 50 mcg fluticasone propionate 250 mcg ATC: R03AK06
Manufacturer: Aeropharm GmbH
-
The medicinal product is intended for the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD). It helps to reduce the number of COPD symptom exacerbations.
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 50 mcg fluticasone propionate 500 mcg ATC: R03AK06
Manufacturer: Aeropharm GmbH
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to prevent shortness of breath and wheezing.
Form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 50 mcg salmeterol xinafoate 36.32 mcg ATC: R03AK06
Manufacturer: Genetic S.p.A Polfarmex S.A.
-
The medicine is used to prevent breathing difficulties occurring in asthma. It helps to prevent shortness of breath and wheezing.
Form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 125 mcg salmeterol xinafoate 36.32 mcg ATC: R03AK06
Manufacturer: Genetic S.p.A
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to prevent shortness of breath and wheezing in the airways.
Form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 250 mcg/dose salmeterol xinafoate 36.32 mcg/dose ATC: R03AK06
Manufacturer: Genetic S.p.A
-
The medicine is used to prevent breathing difficulties caused by asthma (including exercise-induced or nocturnal asthma) and in chronic obstructive pulmonary disease (COPD). It also helps to relieve an attack of shortness of breath or wheezing in the airways, although it does not act immediately.
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 50 mcg ATC: R03AC12
Manufacturer: Polfarmex S.A.
-
The medicine is used in adults and adolescents over 12 years of age to prevent breathing disorders occurring in asthma.
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 50 micrograms/dose fluticasone propionate 100 micrograms/dose ATC: R03AK06
Manufacturer: APL Swift Services (Malta) Ltd. Oy Medfiles Ltd. SPECIAL PRODUCTS LINE S.p.A.
-
The medicine is used in adults and adolescents over 12 years of age to prevent breathing disorders occurring in asthma.
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 50 micrograms/dose fluticasone propionate 250 micrograms/dose ATC: R03AK06
Manufacturer: APL Swift Services (Malta) Ltd. Oy Medfiles Ltd. SPECIAL PRODUCTS LINE S.p.A.
-
The medicine is used in adults and adolescents over 12 years of age to prevent breathing difficulties occurring in asthma or chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 50 micrograms/dose fluticasone propionate 500 micrograms/dose ATC: R03AK06
Manufacturer: APL Swift Services (Malta) Ltd. Oy Medfiles Ltd. SPECIAL PRODUCTS LINE S.p.A.
-
Duexon is used to prevent breathing disorders occurring in asthma. It helps to prevent shortness of breath and wheezing in the airways.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol xinafoate 36.32 mcg fluticasone propionate 50 mcg ATC: R03AK06
Manufacturer: Adamed Pharma S.A.
-
Duexon is used to prevent breathing disorders occurring in asthma. It helps to prevent shortness of breath and wheezing in the airways.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol xinafoate 25 mcg fluticasone propionate 125 mcg ATC: R03AK06
Manufacturer: Adamed Pharma S.A.
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to prevent shortness of breath and wheezing in the airways.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol xinafoate 36.32 mcg fluticasone propionate 250 mcg ATC: R03AK06
Manufacturer: Adamed Pharma S.A.
-
The medicine is used in adults and adolescents over 12 years of age to prevent breathing disorders occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps to prevent shortness of breath and wheezing in the airways.
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 50 mcg fluticasone propionate 100 mcg ATC: R03AK06
Manufacturer: Adamed Pharma S.A.
-
The medicine is used in adults and adolescents over 12 years of age to prevent breathing disorders occurring in asthma or chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 50 mcg fluticasone propionate 250 mcg ATC: R03AK06
Manufacturer: Adamed Pharma S.A.
-
The medicine is used in adults and adolescents from 12 years of age to prevent breathing problems occurring in asthma or chronic obstructive pulmonary disease (COPD). It helps to prevent shortness of breath and wheezing.
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 50 mcg fluticasone propionate 500 mcg ATC: R03AK06
Manufacturer: Adamed Pharma S.A.
-
The medicine is used to prevent breathing problems occurring in asthma. It helps to prevent shortness of breath and wheezing.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol xinafoate 36.32 mcg fluticasone propionate 50 mcg ATC: R03AK06
Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA S.A.
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to prevent shortness of breath and wheezing.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol xinafoate 36.32 mcg fluticasone propionate 125 mcg ATC: R03AK06
Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA SA
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to prevent shortness of breath and wheezing in the airways.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol xinafoate 36.32 mcg fluticasone propionate 250 mcg ATC: R03AK06
Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA SA
-
The medicine is used to prevent breathing disorders, such as asthma and chronic obstructive pulmonary disease (COPD). It helps maintain airway patency and reduces lung swelling and irritation.
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 0.0725 mg fluticasone propionate 0.25 mg ATC: R03AK06
Manufacturer: Cipla Europe NV G.L. Pharma GmbH S&D Pharma CZ, spol. s.r.o.
-
The medicine is used to prevent breathing disorders, such as asthma and chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 0.0725 mg fluticasone propionate 0.5 mg ATC: R03AK06
Manufacturer: Cipla Europe NV G.L. Pharma GmbH S&D Pharma CZ, spol. s.r.o.
-
The medicine is used to prevent breathing difficulties occurring in asthma. It helps to prevent shortness of breath and wheezing.
Form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 125 mcg salmeterol xinafoate 25 mcg ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent breathing difficulties occurring in asthma. It helps to prevent shortness of breath and wheezing.
Form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 250 mcg salmeterol xinafoate 25 mcg ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to maintain airway patency and reduces lung swelling and irritation.
Form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 50 mcg salmeterol xinafoate 25 mcg ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent breathing difficulties occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps to keep the airways open and reduces lung swelling and irritation.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 100 mcg/dose inh. salmeterol xinafoate 50 mcg/dose inh. ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent breathing difficulties occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps to keep the airways open and reduces swelling and irritation in the lungs.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 250 mcg salmeterol xinafoate 50 mcg ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent breathing difficulties occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps to keep the airways open and reduces swelling and irritation in the lungs.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 500 mcg salmeterol xinafoate 50 mcg ATC: R03AK06
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent breathing difficulties caused by asthma (including exercise-induced or nocturnal asthma) and in chronic obstructive pulmonary disease (COPD). It also helps to relieve episodes of shortness of breath or wheezing in the airways, but it does not act immediately.
Form: aerosol, inhalation suspension
Active substance Dosage salmeterol xinafoate 25 mcg ATC: R03AC12
Manufacturer: Aspen Bad Oldesloe GmbH Glaxo Wellcome Production
-
The medicine is used to prevent breathing difficulties caused by asthma (including exercise-induced or nocturnal attacks) and chronic obstructive pulmonary disease (COPD). It helps to keep the airways open, facilitating airflow. It may also help to interrupt episodes of shortness of breath or wheezing, but it does not act immediately.
Form: powder for inhalation
Active substance Dosage salmeterol xinafoate 72.5 mcg ATC: R03AC12
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent breathing disorders occurring in asthma and chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation
Active substance Dosage salmeterol xinafoate 0.0725 mg/1 dose fluticasone propionate 0.25 mg/1 dose ATC: R03AK06
Manufacturer: ELPEN Pharmaceutical Co. Inc.
-
The medicine is used to prevent breathing disorders occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps to maintain airway patency and reduces lung swelling and irritation.
Form: powder for inhalation
Active substance Dosage salmeterol xinafoate 0.0725 mg/1 dose fluticasone propionate 0.5 mg/1 dose ATC: R03AK06
Manufacturer: ELPEN Pharmaceutical Co. Inc.